๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer
NCT06719700Toripalimab, Surufatinib, Chemoradiotherapy, Limited-stage Small Cell Lung Cancer (LS-SCLC)
Sun Yat-sen University
Phase 2
47
Guangzhou
2024-11-30
Not yet open
Third-generation EGFR-TKI Plus Anlotinib as Maintenance for NSCLC With Small Cell Transformation After EGFR-TKI Resistance
NCT06634667Non-small Cell Lung Cancer
Hunan Province Tumor Hospital
Phase 2
30
Changsha
2024-11-30
Recruiting
Temporal Interference for Drug Resistant Epilepsy
NCT06708143Drug Resistant Epilepsy
Xuanwu Hospital, Beijing
Not applicable
30
Beijing
2024-11-30
Recruiting
Different Doses of Sirolimus for the Treatment of Cystic Lymphatic Malformations
NCT06673290Lymphatic Malformation
West China Hospital
Phase 2/3
150
Chengdu
2024-11-30
Active, closed
Safety and Efficacy of the Surpass Evolve Flow Diverter in Treating Intracranial Aneurysms
NCT06731946Intracranial Arterial Aneurysm
Yibin Fang
Observational
150
Shanghai
2024-11-29
Active, closed
A Study of SHR-A2009 Versus Platinum-based Chemotherapy in EGFR-mutated, Advanced or Metastatic NSCLC
NCT06671379Non-small Cell Lung Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
498
Guangzhou
2024-11-29
Recruiting
Single-arm Clinical Trial of TACE in Combination With Icaritin as Adjuvant Therapy After Surgery in Patients With Hepatocellular Carcinoma at High Risk of Recurrence
NCT06644937Hepatocellular Carcinoma (HCC)
Zhujiang Hospital
Phase 2/3
30
Guangzhou
2024-11-29
Recruiting
Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity Therapy
NCT06717412Retinopathy of Prematurity (ROP)
Wang Yusheng
Not applicable
146
Xi'an, Xianyang
2024-11-29
Recruiting
A Study of BGM0504 in Participants with Type 2 Diabetes
NCT06716216Type 2 Diabetes Mellitus (T2DM)
BrightGene Bio-Medical Technology Co., Ltd.
Phase 3
537
Beijing
2024-11-29
Recruiting
The Value of 68Ga-FAPI PET/CT in Preoperative Evaluation of Thyroid Cancer with Lymph Node Metastases
NCT06730529Thyroid Cancer
Ruijin Hospital
Observational
40
Shanghai
2024-11-29
Recruiting
Exploratory Study on Infection and Immunosenescence Based on an Elderly Clinical Cohort
NCT07672522Immunosenescence
Huashan Hospital
Observational
484
Shanghai
2024-11-29
Recruiting
The Safety and Efficacy of Coenzyme I for Injection in Promoting Hematopoietic Recovery of Patients After sUCBT
NCT06558253Hematopoietic Recovery
Anhui Provincial Hospital
Phase 1
12
Hefei
2024-11-29
Recruiting
SBRT, Chemotherapy, and AK104 Neoadjuvant Therapy for Triple-negative Breast Cancer (TNBC)
NCT06401005Breast Cancer
Hubei Cancer Hospital
Phase 2
51
Wuhan
2024-11-28
Recruiting
Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer
NCT06459687Cervical Cancer
Lee's Pharmaceutical Limited
Phase 3
440
Hefei, Beijing, Wuhan, Changsha, Hangzhou
2024-11-28
Recruiting
A Clinical Study of TQB2029 for Injection in Subjects With Multiple Myeloma
NCT06700395Multiple Myeloma
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 1
136
Shanghai, Chengdu
2024-11-28
Active, closed
Correcting Myopia Among Secondary School Children to Increase Academic High School Attendance Rates in Rural Communities
NCT04077086Refractive Errors
Queen's University, Belfast
Not applicable
10,000
Shenyang, Yinchuan
2024-11-28
Active, closed
A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in China
NCT06666855Open Angle Glaucoma, Ocular Hypertension
Santen Pharmaceutical Co., Ltd.
Phase 3
345
Beijing, Guangzhou, Guiyang, Hangzhou, Heilongjiang, Jinan, Lanzhou, Luoyang
2024-11-28
Active, closed
Oncological Safety of Spleen Preservation in Left Pancreatectomy for Pancreatic Ductal Adenocarcinoma (SPLENDID)
NCT07157605Pancreatic Cancer Resectable, Pancreatectomy
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Observational
94
Nanjing
2024-11-28
Recruiting
SBRT, Chemotherapy, and AK112 Neoadjuvant Therapy for Luminal-type Breast Cancer
NCT06402435Breast Cancer
Hubei Cancer Hospital
Phase 2
50
Wuhan
2024-11-28
Recruiting
A Phase I/II Study of HYP-6589 Monotherapy in Treating Advanced Solid Tumors and in Combination With Tyrosine Kinase Inhibitors in Treating Patients With Advanced NSCLC Positive for Driver Genes
NCT06712680Solid Tumor
Sichuan Huiyu Pharmaceutical Co., Ltd
Phase 1/2
115
Guangzhou
2024-11-27
Active, closed
Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis๏ผšBDLL Chinese Cohort
NCT06649721Drug-resistant Tuberculosis, Pulmonary Tuberculosis, Rifampin-resistant Tuberculosis
Huashan Hospital
Phase 3
120
Hefei, Beijing, Xiamen, Nanning, Liupanshui, Shijiazhuang, Harbin, Jiamusi
2024-11-27
Recruiting
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
NCT06526793B-cell Non-Hodgkin Lymphoma, Follicular Lymphoma (FL), Large B-Cell Lymphoma (LBCL)
AstraZeneca
Phase 2
270
Chengdu, Guangzhou, Nanchang, Nanjing, Nantong, Shandong, Shanghai, Tianjin
2024-11-27
Recruiting
A Phase I Study to Investigate the Safety and Tolerability of KGX101 Monotherapy and Combination Therapy With Envafolimab in Advanced or Metastatic Solid Tumor Patients
NCT07260305Advanced or Metastatic Solid Tumors
Kangabio AUSTRALIA LTD PTY
Phase 1
57
Beijing, Shanghai
2024-11-27
Active, closed
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of VSA003 in Chinese HoFH Patients
NCT06712771Homozygous Familial Hypercholesterolemia (HoFH)
Visirna Therapeutics HK Limited
Phase 3
46
Beijing
2024-11-27
Recruiting
Study of Pazopanib Combined With Palbociclib for Refractory Solid Tumors With Co-amplified in the 11q13(FGF3/4/19/CCND1)
NCT06895733Solid Tumor, Adult, Next-generation Sequencing, Precision Medicine
Tianjin Medical University Second Hospital
Phase 1/2
65
Tianjin
2024-11-27
Recruiting
Study on the Application of Intraoperative Optical Coherence Tomography Technique in the Diagnosis and Treatment of Lens Diseases
NCT06687356Lens Diseases
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
600
Hangzhou
2024-11-27
Recruiting
CD70-targeted immunoPET Imaging of Kidney Cancer
NCT06680089Urologic Neoplasms, Urogenital Neoplasms, Kidney Neoplasms, Neoplasms
RenJi Hospital
Phase 2
300
Shanghai
2024-11-27
Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC
NCT06627647Non-squamous Non-small Cell Lung Cancer
AstraZeneca
Phase 3
1,160
Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou
2024-11-27
Recruiting
Fluzoparib With or Without Bevacizumab for Neoadjuvant Therapy in Advanced Ovarian Cancer
NCT06735326Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer
Qilu Hospital of Shandong University
Phase 2
105
Jinan
2024-11-27
Recruiting
Radiotherapy Combined With Fluzopanib and Abiraterone Acetate Tablets (II) Treatment for mCRPC
NCT06971211Metastatic Castration-resistant Prostate Cancer
Jianbin Bi
Phase 2
40
Shenyang
2024-11-27
Active, closed
A Study of SKB264 in Combination With Osimertinib Versus Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutations, Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
NCT06670196Non-Small Cell Lung Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 3
420
Guangzhou
2024-11-27
Recruiting
Nab-TPC vs GP Combined With Camrelizumab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma
NCT06669611Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University
Phase 3
242
Guangzhou
2024-11-27
Recruiting
A Phase III Study Comparing Taletrectinib With Standard Therapy in ROS1 Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients
NCT06564324Non Small Cell Lung Cancer
Nuvation Bio Inc.
Phase 3
194
Hefei, Beijing, Chongqing, Xiamen, Guangzhou, Nanning, Shijiazhuang, Zhengzhou
2024-11-27
Recruiting
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
NCT06634589B-cell Malignancy, Relapsed Cancer, Refractory Cancer, B-cell Lymphoma
BeOne Medicines
Phase 1/2
80
Fuzhou, Guangzhou, Suzhou, Hangzhou, Wenzhou
2024-11-27
Recruiting
The Changes Under Different Accommodation of Anterior Eye and 3D Crystal Reconstruction.
NCT06704503Accommodation
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
120
Hangzhou
2024-11-27
By invitation
Evaluating the Safety and Efficacy of BioTTT001 in Patients With Recurrent/Progressive High-grade Glioma.
NCT06763965Recurrent High-grade Glioma
Beijing Bio-Targeting Therapeutics Technology Co., Ltd
Phase 1/2
30
Beijing
2024-11-26
Recruiting
DCE-MRI Based on 4D Free Breathing for Predicting Preoperative Neoadjuvant Chemoradiotherapy for Esophageal Cancer
NCT06755866Esophageal Cancer
Yunnan Cancer Hospital
Not applicable
135
Kunming
2024-11-26
Active, closed
A Randomized Controlled Trial to Improve the Therapeutic Effect of Robot-assisted Radical Prostatectomy (RARP) Using Indocyanine Green Fluorescence Imaging
NCT06748742Prostate CA
Liu Cheng
Observational
50
Shanghai
2024-11-26
Recruiting
Multicenter, Phase I/II Study to Evaluate the Safety, Tolerability, PK and Efficacy of SCT520FF in Patients With nAMD
NCT06672536nAMD
Sinocelltech Ltd.
Phase 1/2
82
Tianjing
2024-11-26
Recruiting
Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance
NCT06684106Hyperlipidemia, Ursodeoxycholic Acid, Statin Therapy, Glucose Intolerance
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
128
Xi'an
2024-11-25
Recruiting
A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Firmonertinib
NCT06668103Non-Small Cell Lung Cancer With EGFR Mutation
Abbisko Therapeutics Co, Ltd
Phase 2
54
Hefei, Harbin, Wuhan, Changchun, Shanghai
2024-11-25
Recruiting
Safety, Tolerability, and Pharmacokinetics of Single Doses of HC022 in Healthy Subjects.
NCT06657703Systemic Lupus Erythematosus
HC Biopharma Inc.
Phase 1
38
Beijing
2024-11-25
Recruiting
Atrial Shunt for the Treatment of Heart Failure With Reduced Ejection Fraction
NCT07820410Heart Failure With Reduced Ejection Fraction (HFrEF)
Beijing Anzhen Hospital
Phase 2/3
208
Beijing
2024-11-25
Not yet open
Induced Pluripotent Stem Cells Derived Natural Killer Cells Therapy for Refractory and Relaps Acute Myelogenous Leukemia
NCT06702098Acute Myeloid Leukemia (AML)
Guangzhou Ruixin Biotechnological Co., LTD
Phase EARLY_PHASE1
10
Guangzhou
2024-11-25
Recruiting
A Study of ES014 in Subjects With Advanced Solid Tumors
NCT06543056Advanced Solid Tumor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
15
Beijing
2024-11-25
Recruiting
Efficacy and Safety of Minimally Invasive D2+PAND Gastrectomy for Gastric Cancer With PAN Metastasis After Conversion Immunochemotherapy
NCT07056010Gastric Cancer
The First Affiliated Hospital with Nanjing Medical University
Not applicable
30
Nanjing
2024-11-25
Recruiting
The Effect of Different Digestive Tract Reconstruction Methods on Postoperative Quality of Life After Proximal Gastrectomy
NCT06929949Gastroesophageal Junction (GEJ) Cancer, Gastric Cancer
The First Hospital of Jilin University
Observational
90
Changchun
2024-11-25
Not yet open
Anlotinib Plus Nab-Paclitaxels and S-1 for Patients with Advanced Biliary Tract Cancer As Second-Line Treatment
NCT06662877Biliary Tract Cancer, Second Line Treatment, Chemotherapy, Tyrosine Kinase Inhibitor
Sun Yat-sen University
Phase 2/3
206
Guangzhou
2024-11-25
Recruiting
Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases
NCT06688799Autoimmune Diseases
Beijing GoBroad Hospital
Phase 1/2
18
Beijing
2024-11-23
Recruiting
A Study of EH002 Gene Therapy for Otoferlin Gene Mutation-mediated Hearing Loss
NCT06722170DFNB9, Congenital Hearing Loss, Hearing Loss, Sensorineural
Yilai Shu
Not applicable
24
Zhengzhou, Shanghai
2024-11-22
Active, closed
Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study
NCT06494241Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Respiratory Tract Neoplasms, Thoracic Neoplasms
AstraZeneca
Observational
1,000
Anning, Anqing, Changzhi, Daqing, Dazhou, Dazhu, Dingzhou, Ganzhou
2024-11-22
Recruiting
Vitamin C Plus Cordyceps to Chemotherapy Related Anemia in Pancreatic Cancer
NCT06601283Pancreatic Cancer
Fudan University
Phase 2/3
50
Shanghai
2024-11-22
Recruiting
The EEG Study Under Remimazolam Anesthesia in Children
NCT06698705Electroencephalography, Remimazolam, Child Neglect
Second Affiliated Hospital of Wenzhou Medical University
Observational
60
Wenzhou
2024-11-22
Recruiting
The Trend of Copeptin Levels and Its Clinical Value for Postoperative CDI in Pediatric Patients After NSI in ICU
NCT06742060Diabetes Insipidus, Neurohypophyseal, Copeptin Blood Levels, Copeptin, Neurosurgical Intervention
Children's Hospital of Fudan University
Observational
100
Shanghai
2024-11-22
Recruiting
A Phase I/IIa Study of JAB-23E73 in Patients With Advanced Solid Tumors Harboring KRAS Gene Alteration
NCT06959615Advanced Solid Tumor
Jacobio Pharmaceuticals Co., Ltd.
Phase 1/2
334
Hefei, Beijing, Fuzhou, Guangzhou, Nanning, Langfang, Haerbin, Zhengzhou
2024-11-22
Recruiting
Vitamin C Plus Cordyceps to Quality of Life in Patients With Terminal Stage Pancreatic Cancer
NCT06598033Pancreatic Cancer
Fudan University
Phase 2/3
50
Shanghai
2024-11-22
Recruiting
A Phase โ…ข Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
NCT06532006Gastroesophageal-junction Cancer, Monoclonal Antibody, Gastric Cancer, HER2-positive Gastric Cancer
Shanghai Henlius Biotech
Phase 3
550
Baise City, Beijing, Bengbu, Changchun, Changsha, Changzhi, Changzhou, Chengdu
2024-11-22
Recruiting
SHR-A1904 Compared With Investigator's Choice of Therapy in Claudin18.2 Positive Patitens With Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
NCT06649292Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 3
524
Guangzhou
2024-11-22
Active, closed
A Study to Evaluate 611 in Patients With Chronic Rhinosinusitis With Nasal Polyps
NCT06639295Sinusitis, Nasal Polyps
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase 3
243
Beijing
2024-11-22
Recruiting
nTMS for Negative Symptom in Schizophrenia
NCT06642675Schizophrenia
Central South University
Not applicable
40
Changsha
2024-11-22
Recruiting
Clinical Prediction Model for In-Hospital Rebleeding in Acute Non-Variceal Upper Gastrointestinal Bleeding
NCT06697691Acute Non-variceal Upper Gastrointestinal Bleeding
Junwei Yan
Observational
1,000
Wuhan
2024-11-22
Recruiting
A Study of HRS-4642 Monotherapy or in Combination With Adebrelimab in the Treatment of Advanced Biliary Tract Tumors.
NCT06620848Biliary Tract Cancer
Shanghai Zhongshan Hospital
Phase 2
49
Shanghai
2024-11-21
Recruiting
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
NCT06617325Systemic Lupus Erythematosus
UCB Biopharma SRL
Phase 3
450
Baotou, Beijing, Bengbu, Changchun, Changsha, Changzhou, Chengdu, Guangzhou
2024-11-21
Recruiting
A Clinical Trial Evaluating TQB2102 for Injection in Combination With Behmosubaisumab/Payamprolizumab With or Without Chemotherapy in Unresectable Locally Advanced, Recurrent, or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Gastroesophageal Adenocarcinoma
NCT06767800Gastroesophageal Adenocarcinoma
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 2
204
Fuyang, Lu'an, Maanshan, Beijing, Chongqing, Fuzhou, Lanzhou, Wuwei
2024-11-21
Active, closed
Camrelizumab Combined With or Without Apatinib and SOX of Neoadjuvant Treatment for Gastric Cancer
NCT06693128Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
Ruijin Hospital
Phase 2
80
Chengdu, Shanghai, Yantai
2024-11-21
Recruiting
Radiolabelled Nectin-4 Targeted LMW Probe PET/CT in Patients With Lung Lesions
NCT06648317Lung Cancer, Non-Small Cell, Lung Infection
Peking University Cancer Hospital & Institute
Observational
20
Beijing
2024-11-21
Active, closed
A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)
NCT06698042Lung Cancer, Non-Small Cell Lung Cancer
Merck Sharp & Dohme LLC
Phase 3
67
Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Huizhou, Jiangmen, Liuzhou
2024-11-21
Recruiting
Clinical Study of Regulatory T Cells (Tregs) in the Treatment of Neurodegenerative Diseases
NCT06671236Amyotrophic Lateral Sclerosis (ALS)
Novabio Therapeutics
Phase 1
12
Zhengzhou
2024-11-21
Active, closed
A Multi-centered๏ผŒRandomized๏ผŒDouble-blind๏ผŒPlacebo-controlled Study to Evaluate the Efficacy and Safety of SHR-1703 in Eosinophilic Asthma
NCT06653322Asthma With Eosinophilic Phenotype
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 3
401
Chengdu
2024-11-21
By invitation
A Prospective Cohort Study on Ligation of Pancreatic Stump After Distal Pancreatectomy
NCT06814249Distal Pancreatectomy, Postoperative Pancreatic Fistula
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
60
Wuhan
2024-11-21
Recruiting
Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors
NCT06666270Advanced Solid Cancer, Metastatic Solid Tumor, Ovarian Cancer, Breast Cancer
Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd
Phase 1
30
Zhengzhou, Shanghai
2024-11-21
Recruiting
Dolasetron for the Prevention of CINV in Children With Acute Lymphoblastic Leukemia
NCT06756022Chemotherapy Induced Nausea and Vomiting
Anhui Provincial Children's Hospital
Observational
500
Hefei
2024-11-21
Recruiting
Effectiveness and Safety of TIPS Stent Graft in the Treatment of Cirrhosis and Complications of Portal Hypertension
NCT06669806Portal Hypertension Related to Cirrhosis, Ascites Hepatic, Variceal Bleeding
C. R. Bard
Not applicable
166
Changsha
2024-11-21
Recruiting
Micturition Desire-Relaxation Training Device for Lower Urinary Tract Dysfunction in Children
NCT07000656Daytime Urinary Incontinence, Urinary Frequency, Lower Urinary Tract Dysfunction, Primary Nocturnal Enuresis
Shanghai Children's Medical Center
Not applicable
200
Shanghai
2024-11-20
Recruiting
A Prospective Clinical Study of the Combination Therapy of Obutinib or Decitabine with Rituximab, Cyclophosphamide, and Prednisone for the Primary Treatment of Elderly Patients with Newly Diagnosed Diffuse Large B-cell Lymphoma
NCT06683885Newly Diagnosed Diffuse Large B-cell Lymphoma
Mingzhi Zhang
Phase 1/2
80
Zhengzhou
2024-11-20
Recruiting
The Treatment of Sepsis Induced Myocardial Dysfunction With Yiqilishui Formula
NCT06686355Sepsis Induced Myocardial Dysfunction
Dongzhimen Hospital, Beijing
Phase 2
80
Beijing
2024-11-20
Recruiting
Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease
NCT06682169Graft-versus-host Disease
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3
182
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Guangzhou, Nanning
2024-11-20
Recruiting
Study on Aging and Cognitive Impairment in China
NCT06679296Cognitive Dysfunction, Aging
First Affiliated Hospital of Wenzhou Medical University
Observational
20,000
Wenzhou
2024-11-20
Recruiting
Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma
NCT06730308Thymoma
Sun Yat-sen University
Phase 2
45
Guanzhou
2024-11-20
Recruiting
WHO Mental Health Gap Action Program (mhGAP) for Improving Child Mental and Behavioral Disorder Service Quality in China
NCT06702410Neurodevelopmental Disorders
Sun Yat-sen University
Not applicable
375
Zhongshan
2024-11-20
Recruiting
Efficacy and Safety of Peginterferon in ET and PV.
NCT06734637Essential Thrombocythemia, Polycythemia Vera
Zhenya Hong
Not applicable
40
Wuhan
2024-11-20
Recruiting
Ivonescimab in the Treatment of Multiple Advanced Tumors
NCT06683846Pheochromocytoma/Paraganglioma, Rhabdomyosarcoma, Paget Disease, Extramammary, Renal Angiomyolipoma
Fudan University
Phase 2
400
Shanghai
2024-11-20
Recruiting
Analysis of 18F-XTR006 PET Imaging in Cognitively Normal Subjects, and Patients With MCI and AD
NCT07115238Alzheimer Disease, Neurofibrillary Tangle
Sinotau Pharmaceutical Group
Phase 3
354
Beijing
2024-11-20
Recruiting
Low Dose Radiotherapy Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Stage II-III NSCLC
NCT06714708NSCLC, Neoadjuvant Immunotherapy, Low Dose Radiotherapy, Sintilimab
Anhui Provincial Cancer Hospital
Phase 2
86
Hefei
2024-11-20
Recruiting
The Safety and Efficacy of Robotic Assisted Surgery Using Vessel Sealer Extend in Locally Advanced Gastric Cancer
NCT06881043Locally Advanced Gastric Cancer, Gastric Adenocarcinoma
The First Hospital of Jilin University
Observational
300
Changchun
2024-11-20
Not yet open
Qishenyiqi for Ventricular Remodeling After Myocardial Infarction
NCT06699407Chronic Stable Heart Failure
Qilu Hospital of Shandong University
Phase 4
210
Jinan
2024-11-20
Recruiting
A Survey on Growth Development in Children After Liver Transplantation
NCT07574398Growth, Development in Pediatric Liver Transplant Recipients
RenJi Hospital
Observational
275
Shanghai
2024-11-20
Recruiting
Perioperative Tislelizumab for Resectable II-IIIB(N2) KRAS-mutated Nonsquamous Non-small Cell Lung Cancer
NCT06659042Lung Cancer, Non-Small Cell
Shanghai Chest Hospital
Phase 2
32
Shanghai
2024-11-20
Recruiting
Immunobridging/Maintenance Therapy Versus Non-bridging Therapy in CAR-T Therapy for Low-risk R/R B-NHL
NCT06695013B-NHL, CART Therapy
Ruijin Hospital
Phase 2
144
Shanghai
2024-11-20
Not yet open
Washed Microbiota Transplantation in Solid Organ Transplantation
NCT06708676Solid Organ Transplant Complications
The Second Hospital of Nanjing Medical University
Not applicable
50
Nanjing
2024-11-20
Recruiting
Cryoablation Plus Camrelizumab for Advanced Soft Tissue Sarcoma
NCT07602049Soft Tissue Sarcoma (STS), Osteosarcoma
Sun Yat-sen University
Phase 2
57
Guangzhou
2024-11-20
Recruiting
ImmunoPET Imaging of Pancreatic Cancer
NCT06602037Neoplasms Pancreatic
RenJi Hospital
Not applicable
90
Shanghai
2024-11-20
Recruiting
Pharmacokinetic Study of Tranexamic Acid
NCT06728670Ovarian Neoplasm Epithelial
Zhejiang Cancer Hospital
Not applicable
30
Hangzhou
2024-11-20
Recruiting
Effects of Low Tidal Volume and Airway Pressure Release Ventilation on Lung Tissue Mechanics in ARDS Patients Under Mechanical Ventilation: A Prospective Randomized Crossover Study
NCT06790875ARDS (Acute Respiratory Distress Syndrome)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
15
Wuhan
2024-11-20
By invitation
Haemodialysis Alters Hypercoagulability of Blood in Dialysis Patients
NCT07098676Healthy Individuals (Controls), Vascular Surgery Patients With Acute Thrombosis, Dialysis Patients
Ai Peng
Observational
900
Shanghai
2024-11-20
Recruiting
A Deep Learning Model for Diagnosing Lymph Node Metastasis in Nasopharyngeal Carcinoma(NPC)
NCT06829147Nasopharyngeal Cancinoma (NPC), Lymph Node Metastasis
Sun Yat-sen University
Observational
500
Guangzhou
2024-11-19
Recruiting
Firmonertinib Versus Platinum Based Chemotherapy as First-line Treatment for NSCLC With EGFR PACC or EGFR l861q Mutation
NCT06956001EGFR, NSCLC (Advanced Non-small Cell Lung Cancer)
Allist Pharmaceuticals, Inc.
Phase 3
300
Beijing, Shandong
2024-11-19
Recruiting
Physiological Effects and Safety of Continuous High-frequency Oscillatory Ventilation in Mechanical Ventilation Patients
NCT06662630Atelectasis, Acute Respiratory Distress Syndrome, VAP - Ventilator Associated Pneumonia
Shanghai Zhongshan Hospital
Not applicable
30
Shanghai
2024-11-19
Recruiting
Physiological Effects and Safety of Continuous High-frequency Oscillatory Ventilation in ICU Patients
NCT06702813Atelectasis, Postoperative, Hypoxia, Critical Illness
Shanghai Zhongshan Hospital
Not applicable
45
Shanghai
2024-11-19
Active, closed
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
NCT06578247Leukemia
Daiichi Sankyo
Phase 3
700
Beijing, Changchun, Changsha, Chongqing, Guangzhou, Jinan, Nanchang, Nanjing
2024-11-19
Rows per page Showing 10601–10700 of 19052
Previous 105 106 107 108 109 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=107

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.